Global Human Milk Oligosaccharides (HMO) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026

SKU ID : QYR-15954510 | Publishing Date : 23-Jul-2020 | No. of pages : 118

Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces.
North America was the dominant region in terms of production and also consumption, accounting for about 70% of total global share in 2018.

Market Analysis and Insights: Global Human Milk Oligosaccharides (HMO) Market
In 2019, the global Human Milk Oligosaccharides (HMO) market size was US$ 228.7 million and it is expected to reach US$ 1513 million by the end of 2026, with a CAGR of 30.6% during 2021-2026.
Global Human Milk Oligosaccharides (HMO) Scope and Market Size
Human Milk Oligosaccharides (HMO) market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Human Milk Oligosaccharides (HMO) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026.

Segment by Type, the Human Milk Oligosaccharides (HMO) market is segmented into
2'-FL & 3-FL
Sialyllactose
LNT & LNnT
The segment of 2'-FL & 3-FL holds a comparatively larger share in global market, which accounts for about 70%.

Segment by Application, the Human Milk Oligosaccharides (HMO) market is segmented into
Infant Formula
Functional Food & Beverages
Food/Medical Supplements
Other
The baby formula holds an important share in terms of applications, and accounts for 70% of the market share.

Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Competitive Landscape

and Human Milk Oligosaccharides (HMO) Market Share Analysis
Human Milk Oligosaccharides (HMO) market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2015-2020. Details included are company description, major business, Human Milk Oligosaccharides (HMO) product introduction, recent developments, Human Milk Oligosaccharides (HMO) sales by region, type, application and by sales channel.

The major companies include:
Abbott
Inbiose
Elicityl SA
Jennewein Biotechnologie
ZuChem
Dextra Laboratories
Glycom
...

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
market Reports market Reports